This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The treatment of SPS focuses mainly on symptom management, such as myalgias, and reducing the immune system’s hyperactivity. High-dose intravenous immune globulin for stiff-person syndrome. 6 Benzodiazepines have GABA-enhancing properties that can target impaired inhibitory neurotransmitters, which are lacking in SPS. Pract Neurol.
First, a pharmaceuticalcompany could submit an investigational new drug (IND) application for a product with fixed concentrations of cannabinoids to the FDA for approval. First, what types of cannabis will be available to patients? Secondly, how and where will the natural cannabis products be available? There are 2 likely tracks.
This is progressing through a phase 3 trial and includes comparator arms with standard-of-care treatments like daratumumab, bortezomib (Velcade; Millennium/Takeda and Janssen PharmaceuticalCompanies), and lenalidomide. 2 We’re still trying to figure out where these new treatments best fit.
August 1st 2025 Navigating Distrust: Pharma in the Age of Social Media Miranda Schmalfuhs Ian Baer, Founder and CEO of Sooth, discusses how the growing distrust in social media will impact industry marketing strategies and the relationships between pharmaceuticalcompanies and the patients they aim to serve.
In 2022, based upon a complaint filed by a pharmaceuticalcompany, CMS was asked to reevaluate the SSA section that establishes the J-code,” Soefje said. So, the pharmaceuticalcompanies then pushed to get their 505(b)(2) drugs declared sole source,” Soefje said. “If This went into effect in January 2022.”
Backed by more than 40 real-world studies involving 250,000 immunized infants, Beyfortus has consistently proven itself as an effective RSV immunization,” said Thomas Triomphe, Sanofi’se xecutive vice president of vaccines.“To “Our third year of providing RSV protection marks a transformative era in infant health. May 25, 2025.
According to a recent analysis on Pharma Marketing Network , portfolio managers are advising caution in the Asia-Pacific pharmaceutical sector until regulatory clarity and new pricing structures stabilize. Though these companies operate on longer timelines and more complex supply chains, they arent immune. Is the U.S.
Expedition chairman and CEO Yi Larson stated: “We are pleased to be working with Fosun Pharma, one of the leading pharmaceuticalcompanies in China. XH-S004 is an exciting compound that targets neutrophilic inflammation, an important underlying driver of a number of chronic respiratory diseases. “We
July 31st 2025 Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research Miranda Schmalfuhs LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Joshua E Allen, chief scientific officer of Chimerix, a Jazz Pharmaceuticalscompany, stated: “The FDA approval of Modeyso is a milestone moment for the patients and families who have long needed new options, the clinicians who have tirelessly searched for solutions, and the researchers and advocates who never gave up.”
The farsighted pharmaceuticalcompanies are waking up to the importance of AI agents. As regulations become stricter and HCPs become immune to promotional noise, this solution ensures compliance while helping you craft messages that hit home every time (and do so faster). What the Future Holds for Us?
drug prices to be as low as or lower than global prices, targeting 17 major pharmaceuticalcompanies. The President's letters criticize companies for inadequate responses and propose specific steps to comply with the MFN order. John Stanford warns that MFN policies could harm U.S.
We drew on our heritage as a blood bank to develop a platform reminiscent of a blood mobile for mobile collection of patients’ immune cells. This is an opportunity for pharmaceuticalcompanies to support patients via a hub-and-spoke model where the trial might be conducted in Houston but some of the patients live in South Texas.
Strategic Intelligence August 5, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook The imposition of tariffs threatens to elevate costs across the pharmaceutical value chain. This could hinder innovation and pipeline investment, reducing the much-needed pace of therapeutic innovation across the industry.
July 31st 2025 Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research Miranda Schmalfuhs LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
The US department of Health and Human Services (HHS) has culled the 17 Biden-appointed members on the Advisory Committee for Immunization Practices (ACIP) at the Centers for Disease Control and Prevention (CDC) in a move observers warn is liable to further fuel the spread of vaccine-preventable illnesses. lev radin via Shutterstock.
Keytruda is a cancer immunotherapy, which stimulates the immune system to attack tumor cells and is the best-selling medicine in the world. patent expires in 2028. The subcutaneous injection could be given in a doctor’s office every six weeks, instead of requiring a 30-minute IV drip at the same interval.
July 31st 2025 Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research Miranda Schmalfuhs LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
RFK Jr has flip-flopped between endorsing and shunning the MMR vaccine , a shot that is proven to provide strong immunity against the disease. Historically, federal funding has been used to develop vaccines, as infectious disease markets are often not as lucrative as other indications.
It’s been a rough summer for pharmaceuticalcompanies trying to resolve lawsuits by declaring bankruptcy. | The Supreme Court has halted Purdue Pharma’s $6-billion bankruptcy settlement, which granted the company’s former owners—the Sackler family—immunity from civil suits related to the opioid crisis.
It is claimed to have outperformed an antiviral drug in lowering various proinflammatory mediators linked to hyperinflammation and dysfunction of the immune system after viral infection. Qifenda is a broad-spectrum antiviral drug in the commercial stage. Developed by FujiFilm Toyama Chemical, Favipiravir is currently owned by Cellvera.
Janssen PharmaceuticalCompanies of Johnson & Johnson’s Phase III MARIPOSA study is the first to show a clinically meaningful benefit in a chemotherapy-free regimen compared to the small molecule treatment TAGRISSO ® ( osimertinib ).
Cancer monoclonal antibody therapy is a key innovation area in immuno-oncology Monoclonal antibodies are synthetic proteins that target cancer cells directly (targeted therapies) or help improve the immune system’s response to cancer cells (passive immunotherapy).
Povetacicept is under clinical development by Alpine Immune Sciences and currently in Phase I for Systemic Lupus Erythematosus. It provides ALPN-101 and ALPN-303 for the treatment of based immunotherapies and immune synapses to treat cancer and autoimmune and inflammatory diseases. The drug candidate is an engineered B-cell modulator.
In a document outlining the charges against Shafat Quadri, of North Potomac, Maryland the US Department of Justice (DoJ) referred only to “one of the largest pharmaceuticalcompanies in the world” based in New Jersey.
The pharmaceuticalcompany announced that it plans to submit to global health authorities in 2024. appeared first on European Pharmaceutical Review. The REMIX data for Novartis’ novel BTK inhibitor will be presented at an upcoming medical meeting. There were 470 participants in the REMIX-1 study.
The oncology segment has been recognised as one of the most productive areas for pharmaceuticalcompanies to focus their R&D investment. Using a vaccine to utilise the patient’s own immune system to fight cancer is particularly attractive because of the targeted approach made possible by this technology. A broad front.
IL-13 has a role in the immune and inflammatory processes underlying atopic dermatitis signs and symptoms. The monoclonal antibody biologic treatment has been developed to bind to and inhibit the interleukin (IL)-13 cytokine. It inhibits interaction with the IL-13 receptor α1 and α2 subunits (IL-13Rα1 and IL-13Rα2).
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies. AC Immune and F. Hoffmann-La Roche are the other key patent filers in neuro-degenerative receptor binding drug compositions.
Most drugs available for the treatment of UC weaken patients’ immune systems, which puts them at higher risk of infection. Key opinion leaders (KOLs) interviewed by GlobalData have suggested that this group of patients would benefit from a greater number of treatment options that cause less systemic immune-related side effects.
Australian pharmaceuticalcompany Incannex has appointed Quest Pharmaceutical Services (QPS) to advance CannQuit-N (Nicotine), CannQuit-O (Opioid) and Renecann Products in the USA and the European Union (EU). French company Eurofins Scientific is currently developing and manufacturing both products.
Some pharmaceuticalcompanies, including Chiesi, established emergency committees to build business continuity plans and contingencies to protect drug supply and worker safety. Despite COVID-19, we expanded the new business unit to 275 employees in more than 20 countries in just 18 months.
According to GlobalData’s Technology Foresights, which uses over 756,000 patents to analyse innovation intensity for the pharmaceutical industry, there are 110 innovation areas that will shape the future of the industry. The production of antibodies in response to proteins expressed during cancer development serves as a biomarker.
At the same time, lots of people with experience at multinational pharmaceuticalcompanies have chosen to return home. All these factors will support the growth of in-house R&D-driven pharmaceuticalcompanies and bring more innovative drugs to Asian markets.”. Chemotherapy still accounted for 72.6%
The digital transformation is allowing pharmaceuticalcompanies to expand their drug discovery capabilities and accelerate drug development. As Shanaya says, some of the biggest developments have involved mRNA vaccines, “a completely different way to stimulate an immune response.”. Innovation at Pfizer.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content